BioPharma Investor's  Instablog

BioPharma Investor
Send Message
I hold degrees in Biochemistry and Business from NC State University in the heart of RTP, NC. My work experience has been in Microbiology and Pharmacy. I have experience with FDA decisions and Clinical Trials. I seek bargains and low prices, and follow Warren Buffett's principles. At the same... More
My company:
BioPharma Investor
My blog:
BioPharma Investor
  • Cancer Diagnostic Screening Top Emerging Companies: MabCure, Radient Pharmaceuticals, Exact Sciences  1 comment
    Sep 7, 2010 12:35 PM | about stocks: EXAC, RXPC

    Another Cancer Diagnostic Test on my radar is MabCure, Inc., symbol (OTCPK:MBCI). I really like Cancer Diagnostic Testing stocks. They are difficult to find research on these companies and until the testing is approved they are serious cash cows, bleeding cash, and overcome by the dreaded Dilution of share price.

    But once approved, this technology will increase investments ten-fold. They are highly profitable and the return on investment should be good for the companies' stocks. There is an increase in competition from new entrants and established companies. Top Tier companies include Myriad Genetics, Beckman Coulter, Roche, Siemens, Bio-Rad, and BD.

    I focus on emerging testing markets currently seeking approval and MabCure fits that bill, along with Exact Sciences (NASDAQ:EXAS), who is set to disclose their clinical trial Oct. 29, and Radient Pharmaceuticals (RPC) , who has their testing approved and is currently working on sales and validation of product.

    For a quick list of all companies in the market visit the following link:

    Worldwide Market for Cancer Diagnostics

    This article was featured in Marketwatch on MabCure's technology.

    MabCure, Inc. Announces Positive Results for New Ovarian Cancer Diagnostic Blood Test
    Study Results Show 94 Percent Accuracy in Confirming Diagnosis of Ovarian Cancer

    Disclosure: No Position

    Stocks: EXAC, RXPC
Back To BioPharma Investor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (1)
Track new comments
  • BioPharma Investor
    , contributor
    Comments (39) | Send Message
    Author’s reply » Others worth mentioning are iCad, and Mela Sciences.
    7 Sep 2010, 11:46 PM Reply Like
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.